Caribou Biosciences (CRBU) Competitors $1.36 -0.01 (-0.73%) Closing price 03:22 PM EasternExtended Trading$1.36 0.00 (0.00%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRBU vs. SEPN, ORGO, SIGA, CGEM, ATYR, KMDA, ATAI, TRML, MREO, and RGNXShould you be buying Caribou Biosciences stock or one of its competitors? The main competitors of Caribou Biosciences include Septerna (SEPN), Organogenesis (ORGO), Siga Technologies (SIGA), Cullinan Therapeutics (CGEM), aTyr Pharma (ATYR), Kamada (KMDA), atai Life Sciences (ATAI), Tourmaline Bio (TRML), Mereo BioPharma Group (MREO), and REGENXBIO (RGNX). These companies are all part of the "pharmaceutical products" industry. Caribou Biosciences vs. Its Competitors Septerna Organogenesis Siga Technologies Cullinan Therapeutics aTyr Pharma Kamada atai Life Sciences Tourmaline Bio Mereo BioPharma Group REGENXBIO Caribou Biosciences (NASDAQ:CRBU) and Septerna (NASDAQ:SEPN) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Does the media prefer CRBU or SEPN? In the previous week, Caribou Biosciences had 1 more articles in the media than Septerna. MarketBeat recorded 3 mentions for Caribou Biosciences and 2 mentions for Septerna. Caribou Biosciences' average media sentiment score of 0.94 beat Septerna's score of 0.90 indicating that Caribou Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caribou Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Septerna 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer CRBU or SEPN? Caribou Biosciences presently has a consensus target price of $8.50, indicating a potential upside of 525.00%. Septerna has a consensus target price of $26.75, indicating a potential upside of 136.73%. Given Caribou Biosciences' stronger consensus rating and higher probable upside, research analysts clearly believe Caribou Biosciences is more favorable than Septerna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Caribou Biosciences 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Septerna 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is CRBU or SEPN more profitable? Septerna has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,490.84%. Septerna's return on equity of 0.00% beat Caribou Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Caribou Biosciences-1,490.84% -55.70% -45.35% Septerna N/A N/A N/A Which has preferable valuation and earnings, CRBU or SEPN? Septerna has lower revenue, but higher earnings than Caribou Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCaribou Biosciences$9.99M12.66-$149.10M-$1.62-0.84Septerna$1.08M466.23-$71.80MN/AN/A Do institutionals & insiders have more ownership in CRBU or SEPN? 77.5% of Caribou Biosciences shares are held by institutional investors. 8.3% of Caribou Biosciences shares are held by insiders. Comparatively, 4.3% of Septerna shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryCaribou Biosciences beats Septerna on 7 of the 12 factors compared between the two stocks. Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRBU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBU vs. The Competition Export to ExcelMetricCaribou BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$127.42M$2.91B$5.54B$8.95BDividend YieldN/A2.42%5.38%4.08%P/E Ratio-0.8421.4227.3820.03Price / Sales12.66285.81422.31120.16Price / CashN/A41.9536.6357.47Price / Book0.497.518.085.67Net Income-$149.10M-$55.05M$3.16B$248.47M7 Day Performance0.74%3.16%2.12%2.90%1 Month Performance29.52%5.92%4.43%5.75%1 Year Performance-15.00%5.82%35.62%21.36% Caribou Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBUCaribou Biosciences2.3343 of 5 stars$1.36-0.7%$8.50+525.0%-14.4%$127.42M$9.99M-0.84100News CoverageSEPNSepterna1.7165 of 5 stars$10.57+0.6%$26.75+153.1%N/A$468.31M$1.08M0.00N/AORGOOrganogenesis4.0982 of 5 stars$3.66-0.3%$6.00+63.9%+52.3%$465.55M$482.04M-21.53950SIGASiga Technologies1.5901 of 5 stars$6.52+0.9%N/A-14.4%$461.51M$138.72M9.7340CGEMCullinan Therapeutics1.5362 of 5 stars$7.53-3.0%$30.00+298.4%-52.4%$457.95MN/A-2.5930Positive NewsGap UpATYRaTyr Pharma2.9858 of 5 stars$5.07+0.8%$20.20+298.4%N/A$447.69M$230K-6.2653High Trading VolumeKMDAKamada4.1674 of 5 stars$7.75+0.5%$14.67+89.2%+54.8%$443.36M$160.95M26.72360Positive NewsATAIatai Life Sciences3.1375 of 5 stars$2.19-0.5%$8.67+295.7%+111.5%$440.74M$310K-2.4180News CoverageAnalyst ForecastOptions VolumeTRMLTourmaline Bio2.1447 of 5 stars$15.99-3.3%$49.33+208.5%+29.0%$424.84MN/A-4.9844MREOMereo BioPharma Group1.9782 of 5 stars$2.71+1.9%$7.60+180.4%-16.8%$422.94M$10M-38.7140RGNXREGENXBIO4.415 of 5 stars$8.21-2.1%$31.63+285.2%-19.8%$420.85M$83.33M-2.64370 Related Companies and Tools Related Companies Septerna Competitors Organogenesis Competitors Siga Technologies Competitors Cullinan Therapeutics Competitors aTyr Pharma Competitors Kamada Competitors atai Life Sciences Competitors Tourmaline Bio Competitors Mereo BioPharma Group Competitors REGENXBIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRBU) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
